Abstract
Anti-Müllerian hormone (AMH) has long been associated with sexual differentiation in the fetus where in the male it suppresses the development of the female reproductive tracts. More recently it has been shown to be secreted in low concentrations by the granulosa cells of the adult and related to follicular development in the ovary. A number of laboratories are now measuring this hormone as part of IVF treatment and in the investigation of polycystic ovarian disease in particular.
Early immunoassays for this hormone were not stable and currently laboratories are using the assay sold by Beckman Coulter, Inc., the AMH Gen II ELISA. This assay has been developed from two commercial assays purchased by Beckman and is reported to be precise and convenient. It is the assay described here.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kumar A, Kalra B, Patel A et al (2010) Development of a second generation anti-Müllern hormone (AMH) ELISA. J Immunol Methods 362:51–59
Fanchin R, Taieb J, Mendez Lozano DH et al (2005) High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 20:923–927
Broekmans FJ, Visser JA, Laven JSE et al (2008) Anti-Müllerian hormone and ovarian dysfunction. Trends Endocrinol Metab 19:340–347
Long WQ, Ranchin V, Pautier P et al (2000) Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumour by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 85:540–544
Lee MM, Misra M, Donahue PK et al (2003) MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol 211:91–98
Hudson PL, Douglas I, Donahoe PK et al (1990) An immunoassay to detect human Müllerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 70:16–22
Al-Qahtani A, Muttukrishna S, Appasamy M et al (2005) Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the potential clinical applications in males and females. Clin Endocrinol 63:267–273
Lee MM, Donahoe PK, Hasegawa T et al (1996) Müllerian inhibiting substance in humans: normal levels from infancy to childhood. J Clin Endocrinol Metab 81:571–576
Wallace AM, Faye SA, Fleming R et al (2001) A multicentre evaluation of the new Beckman Coulter anti-Müllerian hormone immunoassay (AMH GenII). Ann Clin Biochem 48:370–373
Stegmann BJ, Smith EM, Hunter S et al (2011) Variations in antimüllerian hormone (AMH) level measurements based on method of collection and time lapse between collection and analysis. Fert Steril 96:S200
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Wheeler, M.J. (2013). The Measurement of Anti-Müllerian Hormone (AMH). In: Wheeler, M. (eds) Hormone Assays in Biological Fluids. Methods in Molecular Biology, vol 1065. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-616-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-62703-616-0_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-615-3
Online ISBN: 978-1-62703-616-0
eBook Packages: Springer Protocols